The study involved 411 adult patients with T2DM and was designed as a randomized, double-blind, placebo-controlled trial where patients received varying doses of danuglipron or a placebo
Studies were identified through search of trial registries and databases (Medline, Embase, PsycINFO, CINAHL, Cochrane, Web of Science) from inception through February 2025 for randomized controlled trials, nonrandomized comparative trials, and observational studies
Apply a royal amount to the skin of the body as often as needed or desired
Fine Lines and Wrinkles : Reduces the appearance of premature aging
Start your HeMed consultation hemed.com | Switch to HeMed: hemed.com/switch-to-hemed Start your HeMed consultation hemed.com | Switch to HeMed: hemed.com/switch-to-hemed Blue Light Card holders (NHS and emergency services): 20% discount